Progress in medicine begins long before a treatment reaches the patient. It starts in the preclinical stage, the space where we learn, predict, and refine how therapies behave in living systems.

Among the many tools available to researchers, the porcine model has become one of the most reliable for generating evidence that truly translates to humans. Its cardiovascular, renal, and metabolic systems mirror human physiology with a degree of precision that allows outcomes to be extrapolated with high predictive value (Lab Animal, Nature Portfolio, 2024).

According to Science Translational Medicine (2021), large-animal models such as pigs have increased the success rate of clinical translation by up to 30%, helping reduce costly late-stage failures. This predictive reliability explains why, over the past decade, the use of porcine models in biomedical research has grown by more than 200% (Wiley, Animal Models and Experimental Medicine, 2022).

But beyond data and percentages, what truly matters is what this knowledge enables. Every well-designed preclinical model offers early insight — helping to anticipate risks, optimise formulations, and design safer, more effective therapies. It is in these studies where science begins to take shape as care.

At Versa Biomedical, we use the porcine model not just as a testing platform, but as a living environment for learning and simulation. By recreating real human conditions, we help our partners generate evidence that is both rigorous and meaningful, transforming data into understanding, and understanding into progress.

Because for us, advancing preclinical science is more than predicting outcomes, it is about opening paths where knowledge becomes care, and science becomes purpose.